Clinical trial
KOREAN POST MARKETING SURVEILLANCE TO OBSERVE EFFECTIVENESS AND SAFETY OF PRISTIQ (REGISTERED) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.
NCT02548949 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- KOREAN POST MARKETING SURVEILLANCE TO OBSERVE EFFECTIVENESS AND SAFETY OF PRISTIQ (REGISTERED) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 25, 2016
- Completion date
- February 12, 2020
- Enrollment
- 700 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.